A targeted skeletal health supplement combining Calcium at 500mg with Vitamin D3 at 600IU (15mcg) per tablet. Supports bone density, prevents calcium deficiency, and maintains joint and muscle function. Particularly relevant for growing puppies and kittens, large-breed dogs, senior pets, and breeds with known skeletal vulnerabilities. A focused, single-purpose SKU with a clear clinical rationale
| Composition | Calcium 500mg, Vitamin D3 (600 IU) 15mcg |
| Form | Tablet |
| Standard Pack | 60 Tablets |
| B2B / Bulk Pack | Custom quantities available — 5000 tablets and above, as per client requirement |
| Target Species | Dogs and Cats |
Calcium Vitamin D3 is the most clinically straightforward product in the Grace Pet range — and that is a commercial strength, not a limitation. In a market where supplement formulations are becoming increasingly complex, a product with a clear, single-purpose rationale builds trust with both the recommending professional and the end consumer.
The formulation pairs Calcium at 500mg with Vitamin D3 at 600IU — and the co-formulation is deliberate. Vitamin D3 is not optional in a calcium supplement. It is the essential cofactor that regulates calcium absorption in the small intestine. Without adequate D3, dietary or supplemental calcium passes through the gut largely unabsorbed. Co-formulating both nutrients in a single tablet ensures that the calcium your pet receives is actually being used.
The form of Vitamin D used is D3 (cholecalciferol) — the biologically active form in animals. Vitamin D2 (ergocalciferol), which is cheaper and more common in commodity supplements, has significantly lower bioavailability in dogs and cats. The use of D3 is a formulation decision that reflects the higher standard expected in a GMP-certified manufacturing environment.
For white-label brand positioning, this product has clear life-stage segmentation opportunities. Growing puppies and kittens require higher calcium intake for skeletal development. Large and giant breed dogs are at elevated risk of developmental bone conditions if calcium balance is not managed correctly. Senior pets experience progressive bone density loss and joint deterioration. Each of these segments represents a distinct target audience and a distinct communication strategy.
The product is also a strong recommendation-driver in veterinary and specialist pet retail channels, where the clinical rationale for calcium and D3 supplementation is well understood.
